Best in Biotech 30 Dec 2024 Six biotech companies leading the way in India …rapid identification of selective and potent monoclonal antibodies with the potential to enhance antibody-dependent cellular cytotoxicity (ADCC) activity. Zumutor’s lead candidate, ZM008, is a first-in-class monoclonal antibody that disrupts the… December 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 24 Jul 2023 Sarcoma research: is a breakthrough in sight? …said Davies. Collaborating with researchers at University of California, Los Angeles (UCLA), CancerVAX’s Ewing sarcoma program is making progress, having created seven monoclonal antibody candidates, out of which six have… July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Jun 2025 Six kidney disease companies you should know about in 2025 …Technology: APOL1 inhibitor Lead kidney disease candidate: MZE829 Recent news: Dosed the first patient in a phase 2 trial of MZE829 As a small molecule drug discovery company, Maze Therapeutics… June 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jun 2024 Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024 …with a $35 million series A round. The Georgia company is focused on developing antiviral drugs particularly targeting respiratory viruses. The company’s lead candidate, vapendavir, is a broad-spectrum capsid inhibitor… June 25, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2017 Swiss-US Partners Reveal New Candidate for Autoimmune Disease Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a mini-osmotic pump delivery system to fight autoimmune disease. Numab and Intarcia partnered in 2015 to… September 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Feb 2025 Seven biotech spinouts to watch out for in 2025 …KRAS is the most commonly mutated member of the RAS family, according to a study by Nature. The startup’s lead candidate BBO-8520 is a direct inhibitor that targets the ‘on’… February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Nov 2024 Six antisense oligonucleotide companies shaping the future of genetic medicine …candidate, which recently became the first-ever RNA editing candidate to be tested in clinical trials, Wave Life Sciences also has an antisense oligonucleotide candidate called WVE-003 being tested in a… November 28, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 23 Dec 2022 Merck and Kelun-Biotech collaborating on seven ADC cancer candidates …seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent… December 23, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2020 MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience …is developing vaccine candidates for a number of infectious diseases such as Lassa fever. It also has some immuno-oncology therapies in preclinical development. Themis’ most advanced candidate is a vaccine… May 28, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry …primary focus is on hormone-driven cancers, including breast, ovarian, and endometrial cancers. Context’s lead product candidate, CTIM-76, is a selective Claudin 6 (CLDN6) x CD3 bispecific antibody designed to target… May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Oct 2020 Top 10 Companies Combining AI and Drug Discovery in Europe …Location: Oxford, UK Founded: 2012 Exscientia was one of the first companies to apply AI technology to drug discovery. Its focus is to quickly identify and optimize drug candidates that… October 19, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2025 Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates …or the other – Diakonos’ candidate double loads tumor antigens with both lysate and mRNA, in a design that more closely mimics a viral infection. According to Hartenbach, this approach… February 12, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email